| Literature DB >> 35886639 |
Kinga Humińska-Lisowska1, Jan Mieszkowski1,2, Andrzej Kochanowicz1, Aleksandra Bojarczuk1, Bartłomiej Niespodziński3, Paulina Brzezińska1, Błażej Stankiewicz3, Monika Michałowska-Sawczyn1, Anna Grzywacz4, Miroslav Petr2, Paweł Cięszczyk1.
Abstract
Human adipocytes release multiple adipokines into the bloodstream during physical activity. This affects many organs and might contribute to the induction of inflammation. In this study, we aimed to assess changes in circulating adipokine levels induced by intense aerobic and anaerobic exercise in individuals with different adipose tissue content. In the quasi-experimental study, 48 male volunteers (aged 21.78 ± 1.98 years) were assigned to groups depending on their body fat content (BF): LBF, low body fat (<8% BF, n = 16); MBF, moderate body fat (8-14% BF, n = 19); and HBF, high body fat (>14% BF, n = 13). The volunteers performed maximal aerobic effort (MAE) and maximal anaerobic effort (MAnE) exercises. Blood samples were collected at five timepoints: before exercise, immediately after, 2 h, 6 h, and 24 h after each exercise. The selected cytokines were analyzed: adiponectin, follistatin-like 1, interleukin 6, leptin, oncostatin M, and resistin. While the participants' MAnE and MAE performance were similar regardless of BF, the cytokine response of the HBF group was different from that of the others. Six hours after exercise, leptin levels in the HBF group increased by 35%. Further, immediately after MAnE, resistin levels in the HBF group also increased, by approximately 55%. The effect of different BF was not apparent for other cytokines. We conclude that the adipokine exercise response is associated with the amount of adipose tissue and is related to exercise type.Entities:
Keywords: IL-6; adipose tissue; anaerobic exercise; endurance exercise; leptin; resistin
Mesh:
Substances:
Year: 2022 PMID: 35886639 PMCID: PMC9316284 DOI: 10.3390/ijerph19148782
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 4.614
Physical characteristics of the participants (n = 48).
| Variables | Unit | LBF | MBF | HBF |
|---|---|---|---|---|
| Mean ± SD | Mean ± SD | Mean ± SD | ||
| Height | cm | 181.60 ± 3.85 | 179.23 ± 7.27 | 182.26 ± 7.23 |
| Weight | kg | 74.04 ± 8.03 | 76.20 ± 9.11 | 85.37 ± 11.84 *# |
| BMI | kg/m2 | 22.47 ± 2.58 | 23.89 ± 2.33 | 25.61 ± 2.28 * |
| Skeletal muscle mass | kg | 39.87 ± 4.80 | 39.13 ± 4.66 | 40.12 ± 5.32 |
| Body fat mass | kg | 4.56 ± 1.21 | 8.51 ± 1.80 * | 15.06 ± 4.74 *# |
| Percent body fat | % | 6.15 ± 1.48 | 11.12 ± 1.89 * | 17.46 ± 3.86 *# |
Note: LBF, low body fat; MBF, moderate body fat; HBF, high body fat. * Significant difference vs. LBF at p < 0.05, # significant difference vs. MBF at p < 0.05.
Lipid profile characteristics of the participants (n = 48).
| Variables | Unit | LBF | MBF | HBF |
|---|---|---|---|---|
| Mean ± SD | Mean ± SD | Mean ± SD | ||
| Total cholesterol | mg/dL | 137.00 ± 20.71 | 156.04 ± 31.05 * | 156.31 ± 21.50 * |
| High-density lipoprotein (HDL) cholesterol | mg/dL | 49.47 ± 8.49 | 54.79 ± 16.13 | 46.75 ± 7.31 |
| Low-density lipoprotein (LDL) cholesterol | mg/dL | 75.17 ± 16.81 | 86.08 ± 23.14 | 93.75 ± 20.27 * |
| Cholesterol non-HDL | mg/dL | 88.35 ± 18.65 | 98.20 ± 25.61 | 109.68 ± 24.48 * |
| Triglycerides | mg/dL | 60.35 ± 17.94 | 65.70 ± 18.66 | 78.93 ± 35.53 |
Note: LBF, low body fat; MBF, moderate body fat; HBF, high body fat. * Significant differences vs. LBF at p < 0.05.
Performance characteristics of the participants (n = 48).
| Variables | Unit | LBF | MBF | HBF |
|---|---|---|---|---|
| Mean ± SD | Mean ± SD | Mean ± SD | ||
| Maximal anaerobic effort | ||||
| Relative peak power of the 1st WAnT | W/kg | 10.47 ± 0.99 | 10.57 ± 0.99 | 9.75 ± 0.94 |
| Relative mean power of the 1st WAnT | W/kg | 8.24 ± 0.72 | 8.40 ± 0.66 | 7.87 ± 0.48 |
| Relative peak power of the 2nd WAnT | W/kg | 7.58 ± 0.83 | 7.79 ± 0.70 | 7.56 ± 0.67 |
| Relative mean power of the 2nd WAnT | W/kg | 5.98 ± 0.60 | 5.97 ± 0.54 | 5.53 ± 0.54 |
| Maximal aerobic effort | ||||
| Maximal ventilation | L/min | 148.80 ± 21.83 | 157.41 ± 18.33 | 146.55 ± 26.54 |
| Maximal oxygen uptake | ml/min/kg | 57.72 ± 7.83 | 59.25 ± 5.17 | 55.28 ± 7.97 |
| Maximal heart rate | beats/min | 190.40 ± 9.74 | 188.25 ± 15.55 | 191.33 ± 9.71 |
Note: LBF, low body fat; MBF, moderate body fat; HBF, high body fat; WAnT, Wingate anaerobic test.
Figure 1Changes in the levels of biochemical markers ((A)—adiponectin, (B)—follistatin like 1, (C)—interleukin 6, (D)—leptin, (E)—oncostatin, (F)—resistin) after the double 30 s Wingate anaerobic test (means and standard deviations are shown) in the low body fat (blue), moderate body fat (green), and high body fat (red) groups. I, baseline; II, immediately after exercise; III, 2 h after exercise; IV, 6 h after exercise; V, 24 h after exercise. Significant difference vs. * low body fat group 24 h after exercise at p < 0.05; # moderate body fat group 24 h after exercise at p < 0.05; † high body fat group immediately after exercise at p < 0.05. ^ Significant difference vs. high body fat group at baseline, immediately after, and 6 and 24 h after exercise at p < 0.05. MAnE exerts significant interactions between the group and RM factor on leptin and resistin ((D) and (F), respectively).
Two-way (3 groups × 5 repeated measures) ANOVA of biochemical marker levels induced by a double 30 s Wingate anaerobic test in low, moderate, and high body fat groups.
| Variable | Effect | F | df | Effect Size (η2) | Post Hoc Outcome | |
|---|---|---|---|---|---|---|
| Adiponectin | Group | 3. 85 | 2, 45 | 0.02 * | 0.14 | LBF < MBF |
| Follistatin-like 1 | Group | 1.74 | 2, 45 | 0.18 | 0.07 | II > I, III, IV, V; V < I, III, IV |
| Interleukin 6 | Group | 1.45 | 2, 45 | 0.25 | 0.05 | |
| Leptin | Group | 7.22 | 2, 45 | <0.01 ** | 0.24 | LBF < HBF |
| Oncostatin | Group | 0.65 | 2, 45 | 0.52 | 0.02 | V < I, III, IV |
| Resistin | Group | 0.66 | 2, 45 | 0.52 | 0.02 | II > I, IV, V; V < III |
Note: LBF, low body fat; MBF, moderate body fat; HBF, high body fat; I, baseline; II, immediately after exercise; III, 2 h after exercise; IV, 6 h after exercise; V, 24 h after exercise. * Significant difference at p < 0.05, ** significant difference at p < 0.01.
Figure 2Changes in the levels of biochemical markers ((A)—adiponectin, (B)—follistatin like 1, (C)—interleukin 6, (D)—leptin, (E)—oncostatin, (F)—resistin) after the Bruce treadmill test (means and standard deviations are shown) in the low body fat (blue), moderate body fat (green), and high body fat (red) groups. I, baseline; II, immediately after exercise; III, 2 h after the exercise; IV, 6 h after exercise; V, 24 h after exercise. †† Significant difference vs. high body fat group before and immediately after exercise, vs. low and moderate body fat group 6 h after exercise. MAE exerts a significant interaction between the group and RM factor on leptin (D).
Two-way (3 groups × 5 repeated measures) ANOVA of biochemical marker levels induced by the Bruce treadmill test in low, moderate, and high body fat groups.
| Variable | Effect | F | df | Effect Size (η2) | Post Hoc Outcome | |
|---|---|---|---|---|---|---|
| Adiponectin | Group | 1.12 | 2, 45 | 0.33 | 0.05 | |
| Follistatin-like 1 | Group | 0.54 | 2, 45 | 0.58 | 0.03 | II > V > I, III, IV |
| Interleukin 6 | Group | 3.77 | 2, 45 | 0.04 * | 0.05 | MBF > HBF |
| Leptin | Group | 6.32 | 2, 45 | <0.01 ** | 0.24 | LBF, MBF < HBF |
| Oncostatin | Group | 3.36 | 2, 45 | 0.05 * | 0.13 | MBF > HBF |
| Resistin | Group | 0.39 | 2, 45 | 0.67 | 0.02 | I, IV, V < II, III |
Note: LBF, low body fat; MBF, moderate body fat; HBF, high body fat; RM, repeated measure; I, baseline; II, immediately after exercise; III, 2h after exercise; IV, 6 h after exercise; V, 24 h after exercise. * Significant difference at p < 0.05, ** significant difference at p < 0.01.